Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC.
暂无分享,去创建一个
J. Lee | A. Schenk | S. Y. Kim | Y. Jeong | H. Laue | J. Yoon | Joon-Il Choi | Longquan Chen | S. Kim
[1] S. Du,et al. Using Dynamic 99mTc-GSA SPECT/CT Fusion Images for Hepatectomy Planning and Postoperative Liver Failure Prediction , 2015, Annals of Surgical Oncology.
[2] Kyung-Suk Suh,et al. Feasibility of three-dimensional virtual surgical planning in living liver donors , 2015, Abdominal Imaging.
[3] Jean-Luc Daire,et al. Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. , 2015, Radiology.
[4] Joon Koo Han,et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. , 2015, Radiology.
[5] A. Ba-Ssalamah,et al. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. , 2014, Radiology.
[6] Joon Koo Han,et al. Monopolar Radiofrequency Ablation Using a Dual-Switching System and a Separable Clustered Electrode: Evaluation of the In Vivo Efficiency , 2014, Korean journal of radiology.
[7] B. Choi,et al. Dual Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: Comparison with Consecutive and Switching Monopolar Modes in Ex Vivo Bovine Livers , 2013, Korean journal of radiology.
[8] Seonwoo Kim,et al. Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[9] A. Schinkel,et al. Hepatocyte Hopping of OATP1B Substrates Contributes to Efficient Hepatic Detoxification , 2012, Clinical pharmacology and therapeutics.
[10] A. Ruzzenente,et al. How Much Remnant Is Enough in Liver Resection? , 2012, Digestive Surgery.
[11] J. Prieto,et al. Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. , 2012, Journal of hepatology.
[12] Kunio Doi,et al. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. , 2011, Radiology.
[13] M. Schultze-Mosgau,et al. Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment , 2011, Investigative radiology.
[14] H. Nilsson. Magnetic resonance imaging for the assessment of liver function , 2011 .
[15] Jürgen Weitz,et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). , 2011, Surgery.
[16] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[17] T. Gruenberger,et al. Evaluation of Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastases Using Indocyanine Green Clearance Testing , 2011, Annals of Surgical Oncology.
[18] A. Nordell,et al. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[19] J. Bruix,et al. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.
[20] M. Niemi,et al. Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.
[21] A. Nordell,et al. Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte‐specific contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[22] B. Bell,et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.
[23] M. Vivarelli,et al. Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] O. Farges,et al. The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.
[25] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[26] Heather Rhule,et al. The Process of Evaluation and Documentation of Crash Test Dummies for Part 572 of the Code of Federal Regulations , 2005 .
[27] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[28] L. Ellis,et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients , 2004, Annals of Surgical Oncology.
[29] A. Burroughs,et al. Hepatocellular carcinoma , 2003, The Lancet.
[30] K. Zou,et al. Correlation and simple linear regression. , 2003, Radiology.
[31] N. Furumoto,et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. , 2001, Archives of surgery.
[32] T. Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001 .
[33] Y. Matsui,et al. Preoperative determination of the surgical procedure for hepatectomy using technetium‐99m‐galactosyl human serum albumin (99mTc‐GSA) liver scintigraphy , 1997, Hepatology.
[34] G. T. Krishnamurthy,et al. Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.